Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Cancer|March 2, 2013
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosisAnja Bruchmann, Corinna Roller, Tamara Vanessa Walther, et al.
International Journal of Molecular Sciences|June 6, 2013
Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoIris E Eder, Martina Egger, Hannes Neuwirt, et al.
The Prostate|October 15, 2010
The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detectionHuajie Bu, Stefanie Bormann, Georg Schäfer, et al.
Nature|October 23, 2014
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 systemDanilo Maddalo, Eusebio Manchado, Carla P Concepcion, et al.
Plos One|September 30, 2016
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic CholangiocarcinomaCamilo Correa-Gallego, Danilo Maddalo, Alexandre Doussot, et al.
Plos One|October 11, 2012
A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell deathDanilo Maddalo, Antje Neeb, Katja Jehle, et al.
Lab on a Chip|August 18, 2023
Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studiesCharlotte Bouquerel, Anastasiia Dubrova, Isabella Hofer, et al.
Molecular Cancer Therapeutics|July 8, 2025
KRAS codon-specific mutations differentially toggle PI3K pathway signaling and alter sensitivity to inavolisib (GDC-0077)Kyung W Song, Christy C Ong, Eva Lin, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cellsMyriam Lemmens, Benoit Fischer, Michael Zogg, et al.
Cancer Research|March 5, 2026
The Hippo Pathway is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1 Resistant CancerJuliette Roels, Hamid Ghaedi, Jayaram Kancherla, et al.
Pageof 4